Jin Qian is a highly skilled professional with 17 years of biopharmaceutical industry experience, specializing in Manufacturing and R&D functions. Currently serving as the Director/Principal Scientist in Regulatory Affairs for CMC biologics at Merck, Jin leads several global regulatory CMC submissions related to Keytruda and oversees the preparation of analytical templates for regulatory filings. Previously, Jin held roles at Bristol-Myers Squibb, ImClone Systems, and Merck, working extensively on analytical strategies and quality control for various biologics. Jin holds a Ph.D. from the Swedish University of Agricultural Sciences and has completed postdoctoral research at the Massachusetts Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices